tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
Holding RAPP?
Track your performance easily

Rapport Therapeutics, Inc. (RAPP) Cash flow

19 Followers

Rapport Therapeutics, Inc. Cash Flow

RAPP's free cash flow for Q3 2024 was $-16.55M. For the 2024 fiscal year, RAPP's free cash flow was decreased by $― and operating cash flow was $-16.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 23
Operating Cash Flow
$ -27.18M
Investing Cash Flow
$ -78.86M
Financing Cash Flow
$ 145.14M
Cash Flow From Discontinued Operation
-
Other Cash Adjustment Inside Changein Cash
-
End Cash Position
$ 70.25M
Income Tax Paid Supplemental Data
-
Interest Paid Supplemental Data
-
Issuance Of Capital Stock
$ 54.00K
Issuance Of Debt
-
Repayment Of Debt
-
Free Cash Flow
$ -28.82M
Domestic Sales
-
Foreign Sales
-
Currency in USD

Rapport Therapeutics, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis